000 01442 a2200397 4500
005 20250517082233.0
264 0 _c20171130
008 201711s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.7539
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGardella, Kacie A
245 0 0 _aAryl hydrocarbon receptor nuclear translocator (ARNT) isoforms control lymphoid cancer cell proliferation through differentially regulating tumor suppressor p53 activity.
_h[electronic resource]
260 _bOncotarget
_cMar 2016
300 _a10710-22 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlternative Splicing
650 0 4 _aAryl Hydrocarbon Receptor Nuclear Translocator
_xmetabolism
650 0 4 _aCell Differentiation
_xphysiology
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xphysiology
650 0 4 _aDoxorubicin
_xpharmacology
650 0 4 _aHumans
650 0 4 _aJurkat Cells
650 0 4 _aLymphoma
_xmetabolism
650 0 4 _aProtein Isoforms
650 0 4 _aSignal Transduction
650 0 4 _aTumor Suppressor Protein p53
_xmetabolism
700 1 _aMuro, Israel
700 1 _aFang, Gloria
700 1 _aSarkar, Krishnakali
700 1 _aMendez, Omayra
700 1 _aWright, Casey W
773 0 _tOncotarget
_gvol. 7
_gno. 10
_gp. 10710-22
856 4 0 _uhttps://doi.org/10.18632/oncotarget.7539
_zAvailable from publisher's website
999 _c25764507
_d25764507